TokenPost·
enVVeno Medical Posts $6.29 Q3 Loss Per Share, Targets Year-End Enrollment
The company expects its first TAVVE study patient before the end of 2026. The initial stage is expected to include up to 10 patients.
More news
- TokenPost1INCH Falls 13% After 1inch Says Token Was Stolen From Binance
- Crypto BriefingBitcoin short-term holders sell at loss for first time in 72 days
- TokenPostAdrian Flux Adds Humanoid Robot Coverage to UK Home Insurance
- TokenPostFBI Coordinates With Partners to Assess Binance Hack’s Potential Impact
- TokenPostRealty Income Q3 Results Due Monday as Analysts Forecast $1.45B in Revenue
- Bitcoin.com NewsBitcoin ETFs Add $441M in 4 Days as Zcash Streak Hits Day 8